Literature DB >> 8755580

A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.

D Califano1, A D'Alessio, G L Colucci-D'Amato, G De Vita, C Monaco, G Santelli, P P Di Fiore, G Vecchio, A Fusco, M Santoro, V de Franciscis.   

Abstract

Germ-line missense mutations of the receptor-like tyrosine kinase ret are the causative genetic event of the multiple endocrine neoplasia (MEN) type 2A and type 2B syndromes and of the familial medullary thyroid carcinoma. We have used the rat pheochromocytoma cell line, PC12, as a model system to investigate the mechanism or mechanisms by which expression of activated ret alleles contributes to the neoplastic phenotype in neuroendocrine cells. Here we show that stable expression of ret mutants (MEN2A and MEN2B alleles) in PC12 cells causes a dramatic conversion from a round to a flat morphology, accompanied by the induction of genes belonging to the early as well as the delayed response to nerve growth factor. However, in the transfected PC12 cells, the continuous expression of neuronal specific genes is not associated with the suppression of cell proliferation. Furthermore, expression of ret mutants renders PC12 cells unresponsive to nerve growth factor-induced inhibition of proliferation. These results suggest that induction of an aberrant pattern of differentiation, accompanied by unresponsiveness to growth-inhibitory physiological signals, may be part of the mechanism of action of activated ret alleles in the pathogenesis of neuroendocrine tumors associated with MEN2 syndromes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755580      PMCID: PMC38852          DOI: 10.1073/pnas.93.15.7933

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The Wnt-1 proto-oncogene induces changes in morphology, gene expression, and growth factor responsiveness in PC12 cells.

Authors:  G M Shackleford; K Willert; J Wang; H E Varmus
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

2.  The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction.

Authors:  K W Wood; H Qi; G D'Arcangelo; R C Armstrong; T M Roberts; S Halegoua
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

3.  Expression of TRK-T1 oncogene induces differentiation of PC12 cells.

Authors:  A Greco; R Orlandi; C Mariani; C Miranda; M G Borrello; A Cattaneo; S Pagliardini; M A Pierotti
Journal:  Cell Growth Differ       Date:  1993-07

Review 4.  Oncogenes and protein kinases in neuronal growth-factor action.

Authors:  K W Wood; T M Roberts
Journal:  Biochim Biophys Acta       Date:  1993-08-23

5.  A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions.

Authors:  G D'Arcangelo; S Halegoua
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

Authors:  H Donis-Keller; S Dou; D Chi; K M Carlson; K Toshima; T C Lairmore; J R Howe; J F Moley; P Goodfellow; S A Wells
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

7.  Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism.

Authors:  K E Boulukos; E B Ziff
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

Authors:  M Santoro; W T Wong; P Aroca; E Santos; B Matoskova; M Grieco; A Fusco; P P di Fiore
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.

Authors:  R M Hofstra; R M Landsvater; I Ceccherini; R P Stulp; T Stelwagen; Y Luo; B Pasini; J W Höppener; H K van Amstel; G Romeo
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

10.  Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.

Authors:  K M Carlson; S Dou; D Chi; N Scavarda; K Toshima; C E Jackson; S A Wells; P J Goodfellow; H Donis-Keller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more
  6 in total

1.  Identification of a key motif that determines the differential surface levels of RET and TrkB tyrosine kinase receptors and controls depolarization enhanced RET surface insertion.

Authors:  Xue-Zhi Li; Jing Yan; Shu-Hong Huang; Ling Zhao; Jue Wang; Zhe-Yu Chen
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

2.  Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma.

Authors:  S Gullu; A Gursoy; M F Erdogan; S Dizbaysak; G Erdogan; N Kamel
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

3.  The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret.

Authors:  Laura Cerchia; Domenico Libri; Maria Stella Carlomagno; Vittorio de Franciscis
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

4.  Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase.

Authors:  Laura Cerchia; Frédéric Ducongé; Carine Pestourie; Jocelyne Boulay; Youssef Aissouni; Karine Gombert; Bertrand Tavitian; Vittorio de Franciscis; Domenico Libri
Journal:  PLoS Biol       Date:  2005-03-22       Impact factor: 8.029

5.  Ruta graveolens L. induces death of glioblastoma cells and neural progenitors, but not of neurons, via ERK 1/2 and AKT activation.

Authors:  Maria Teresa Gentile; Claudia Ciniglia; Mafalda G Reccia; Floriana Volpicelli; Monica Gatti; Stefano Thellung; Tullio Florio; Mariarosa A B Melone; Luca Colucci-D'Amato
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications.

Authors:  Yan-Jun Wan; Li-Xi Liao; Yang Liu; Heng Yang; Xiao-Min Song; Li-Chao Wang; Xiao-Wen Zhang; Yi Qian; Dan Liu; Xiao-Meng Shi; Li-Wen Han; Qing Xia; Ke-Chun Liu; Zhi-Yong Du; Yong Jiang; Ming-Bo Zhao; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.